Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Epistatic gene-gene interactions could contribute to the heritability of complex multigenic disorders, but few examples have been reported. Here, we focus on the role of aberrant dopaminergic signaling, involving the dopamine transporter DAT, a cocaine target, and the dopamine D2 receptor, which physically interacts with DAT. Splicing polymorphism rs2283265 of DRD2, encoding D2 receptors, were shown to confer risk of cocaine overdose/death (odds ratio ∼3) in subjects and controls from the Miami Dade County Brain Bank.(1) Risk of cocaine-related death attributable to the minor allele of rs2283265 was significantly enhanced to OR=7.5 (P=0.0008) in homozygous carriers of the main 6-repeat allele of DAT rs3836790, a regulatory VNTR in intron8 lacking significant effect itself. In contrast, carriers of the minor 5-repeat DAT allele showed no significant risk (OR=1.1, P=0.84). DAT rs3836790 and DRD2 rs2283265 also interacted by modulating DAT protein activity in the ventral putamen of cocaine abusers. In high-linkage disequilibrium with the VNTR, DAT rs6347 in exon9 yielded similar results. Assessing the impact of DAT alone, a rare DAT haplotype formed by the minor alleles of rs3836790 and rs27072, a regulatory DAT variant in the 3'-UTR, occurred in nearly one-third of the cocaine abusers but was absent in African American controls, apparently conferring strong risk. These results demonstrate gene-gene-drug interaction affecting risk of fatal cocaine intoxication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mystery of missing heritability: Genetic interactions create phantom heritability
Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119675109 · Cited by 1,542 · cited 2×
“Genetic factors contribute to complex human traits and diseases, but the extent of genetic influence often remains uncertain.2 Addressing the ‘mystery of missing heritability’, Zuk et al.3 posit that interactions among loci (epistasis) may account at least in part for the gap between known genetic risk factors and est…”
BackgroundThe evolutionary significance of cis-regulatory mutations
Wray, G. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2063 · Cited by 1,521 · cited 1×
“In humans, several genes involved in behavioral modulation carry frequent variants, often regulating gene expression and mRNA processing or translation.(12,13) As these variants may be considered to reside within a normal range, they are typically not recognized as disease risk factors in GWAS analyses, but in the con…”
BackgroundDistinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717 · cited 1×
“main splice variants, a short form lacking exon6 (D2S) and a long form including exon6 (D2L).(18,19) Unlike D2L, D2S is”
BackgroundProminence of the dopamine D2 short isoform in dopaminergic pathways
Khan, Z. U., Mrzljak, L., Gutierrez, A., de la Calle, A., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7731 · Cited by 278 · cited 1×
“main splice variants, a short form lacking exon6 (D2S) and a long form including exon6 (D2L).(18,19) Unlike D2L, D2S is”
BackgroundGene–gene interaction associated with neural reward sensitivity
Yacubian, J., Sommer, T., Schroeder, K., Gläscher, J., Kalisch, R., Leuenberger, B., Braus, D. F., & Büchel, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702029104 · Cited by 241
Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy
Ciccarone, D. (2011) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2010.11.004 · Cited by 200
Franke, B., Vasquez, A. A., Johansson, S., Hoogman, M., Romanos, J., Boreatti-Hümmer, A., Heine, M., Jacob, C. P., Lesch, K.-P., Casas, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.170 · Cited by 183
Pinsonneault, J. K., Han, D. D., Burdick, K. E., Kataki, M., Bertolino, A., Malhotra, A. K., Gu, H. H., & Sadee, W. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.45 · Cited by 147 · cited 11×
“For DAT evidence see Pinsonneault et al.(24) Genomic location of these variants is shown in Supplementary Figure 1.”
BackgroundMethodResultInfluentialSelf-citation
Cited by
Next generation sequencing and its applications in forensic genetics
Børsting, C., & Morling, N. (2015) · Forensic Science International: Genetics · doi:10.1016/j.fsigen.2015.02.002 · Cited by 460
Shi, S., Leites, C., He, D., Schwartz, D., Moy, W., Shi, J., & Duan, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535203 · Cited by 61
“Post-transcriptionally, two intronic SNPs, rs2283265 (intron 5) and rs1076560 (intron 6), in high linkage disequilibrium (LD) with each other, alter DRD2 splicing (29) and are associated with reduced performance in working memory in controls (29) and with cocaine abuse (30, 31).”
BackgroundAssociation of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder
Gadow, K. D., Pinsonneault, J. K., Perlman, G., & Sadee, W. (2014) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2014.04.007 · Cited by 49
Self-citationRoussotte, F. F., Gutman, B. A., Hibar, D. P., Madsen, S. K., Narr, K. L., Thompson, P. M., & (ADNI), A. D. N. I. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.011 · Cited by 19
Metadata
- Authors
- Sullivan, D., Pinsonneault, J. K., Papp, A. C., Zhu, H., Lemeshow, S., Mash, D. C., & Sadee, W.
- Venue
- Translational Psychiatry
- Published
- 2013-01-22
- Volume
- 3
- Issue
- 1
- Pages
- e222-e222
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2077913018
- Cited by
- 69
- References
- 8
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.